• Animal Bioscience
• /
• 제34권5호
• /
• pp.867-879
• /
• 2021

Objective: Fibronectin 3 (FN3) and immunoglobulin like modules (Ig) are usually collocated beside modular cellulase catalytic domains. However, very few researches have investigated the role of these modules. In a previous study, we have sequenced and analyzed bacterial metagenomic DNA in Vietnamese goats' rumen and found that cellulase-producing bacteria and cellulase families were dominant. In this study, the properties of modular cellulases and the role of a FN3 in unique endoglucanase belonging to glycosyl hydorlase (GH) family 5 were determined. Methods: Based on Pfam analysis, the cellulases sequences containing FN3, Ig modules were extracted from 297 complete open reading frames (ORFs). The alkaline, thermostability, tertiary structure of deduced enzymes were predicted by AcalPred, TBI software, Phyre2 and Swiss models. Then, whole and truncated forms of a selected gene were expressed in Escherichia coli and purified by His-tag affinity column for assessment of FN3 ability to enhance enzyme activity, solubility and conformation. Results: From 297 complete ORFs coding for cellulases, 148 sequences containing FN3, Ig were identified. Mostly FN3 appeared in 90.9% beta-glucosidases belonging to glycosyl hydrolase family 3 (GH3) and situated downstream of catalytic domains. The Ig was found upstream of 100% endoglucanase GH9. Rarely FN3 was seen to be situated downstream of X domain and upstream of catalytic domain endoglucanase GH5. Whole enzyme (called XFN3GH5 based on modular structure) and truncate forms FN3, XFN3, FN3GH5, GH5 were cloned in pET22b (+) and pET22SUMO to be expressed in single and fusion forms with a small ubiquitin-related modifier partner (S). The FN3, SFN3 increased GH5 solubility in FN3GH5, SFN3GH5. The SFN3 partly served for GH5 conformation in SFN3GH5, increased modules interaction and enzyme-soluble substrate affinity to enhance SXFN3GH5, SFN3GH5 activities in mixtures. Both SFN3 and SXFN3 did not anchor enzyme on filter paper but exfoliate and separate cellulose chains on filter paper for enzyme hydrolysis. Conclusion: Based on these findings, the presence of FN3 module in certain cellulases was confirmed and it assisted for enzyme conformation and activity in both soluble and insoluble substrate.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
• /
• pp.231.3-232
• /
• 2003

The biomedical applications of chitosan have been widely researched. FN mediates its biological effects through binding to the hetero-dimeric transmembrane glycoproteins, integrins, which physically couple the cytoskeleton to the ECM. FN binds to the integrin through a consensus site including the Arg-Gly-Asp (RGD) sequence within tenth type III module (Ruoslahti & Pierschbacher 1987). A short sequence Pro-His-Ser-Arg-Asn (PHSRN) has also been identified as a synergistic motif within ninth type III module for binding to ${\alpha}$5${\beta}$1 integrin (Aota et al. 1994). (omitted)

• 대한방사성의약품학회지
• /
• 제3권2호
• /
• pp.91-97
• /
• 2017

$^{18}F-THK-5351$ is a PET radiotracer to image the hyperphosphorylated tau fibrillar aggregates in human brain. This protocol describes the optimized radiosynthesis of $^{18}F-THK-5351$ using a commercial GE $TRACERlab^{TM}$ $FX_{FN}$ radiosynthesis module. $^{18}F-THK-5351$ was prepared by nucleophilic [$^{18}F$]fluorination from its protected tosylate precursors, (S)-(2-(2-methylaminopyrid-5-yl)-6-[[2-(tetrahydro-2H-pyran-2-yloxy)-3-tosyloxy]propoxy] quinolone(THK-5352), at $110^{\circ}C$ for 10 min in dimethyl sulfoxide, followed by deprotection with 1 N HCl. The average radiochemical yield of $^{18}F-THK-5351$ was $31.9{\pm}6.7%$(decay-corrected, n = 10), with molar activity of $198.1{\pm}33.9GBq/{\mu}mol$($5.4{\pm}0.9Ci/{\mu}mol$, n = 10). The radiochemical purity was determined to be above 98%. The overall production time including HPLC purification is approximately 70 min. This fully-automated protocol is validated for clinical use.

• 대한방사성의약품학회지
• /
• 제6권2호
• /
• pp.61-68
• /
• 2020

Aggregated neurofibrillary tangles (NFTs) are a pathological hallmark in Alzheimer's disease (AD) and many radiopharmaceuticals targeting NFTs have been developed so far. Among these, [¹⁸F]flortaucipir (TAUVID^TM) is the first approved radiopharmaceutical in the Food and Drug Administration (FDA) to image tau pathology. In the present study, we describe the optimized radiosynthetic method for the routine production of [¹⁸F] flortaucipir using a commercialized automation module (i.e. GE TRACERlab^TM FX_FN pro). [¹⁸F]Flortaucipir was prepared by nucleophilic substitution from its N-tert-butoxycarbonyl protected nitro precursor, tertbutyl 7-(6-nitropyridin-3-yl)-5H-pyrido[4,3-b]indole-5-carboxylate, at 130℃ for 10 min in dimethyl sulfoxide. The mean radiochemical yield was 20 ± 4.3% (decay-corrected, n = 47) with the molar activity of 218 ± 32 GBq/µmol at the end of synthesis. The radiochemical purity was determined to be above 95%. The overall production time including quality control is approximately 100min. The final produced [¹⁸F]flortaucipir injection meets the USP criteria for quality control. Thus, this fully automated system is validated for clinical use.

• 핵의학기술
• /
• 제22권1호
• /
• pp.51-54
• /
• 2018

본 연구는 타우 PET용 방사성의약품으로 개발된 $^{18}F-THK5351$의 임상적용을 위하여 상용화된 자동 합성장치에 적용한 표지방법을 개발하고자 하였다. $^{18}F-THK5351$의 표지법 개발은 HPLC 분리정제 전 표지반응물의 유기용매, 불순물 및 미반응 물질을 제거하기 위해 고체상 추출 카트리지를 사용하여 정제하는 과정을 포함한 방법(method I)과 전처리 정제과정을 포함하지 않은 방법(method II)으로 나누어 진행하였다. $^{18}F-THK5351$ 표지는 $Sep-Pak^{(R)}$ QMA 카트리지를 사용하여 흡착한 불소-18 음이온을 $K_{2.2.2}/K_2CO_3$으로 용출한 후 $100^{\circ}C$에서 진공상태와 헬륨의 흐름하에 건조한 후 표지 전구체와 $110^{\circ}C$에서 10분간 반응시켰다. 반응 후 1 N HCl을 첨가하여 보호기를 제거한 후 0.8 M $CH_3COOK$를 사용하여 표지 반응물을 중화하였다. 이후 전처리 정제의 유무에 따라 method I과 method II로 진행하였다. Method I에서 전처리 정제 과정의 최적화를 위해 $Sep-Pak^{(R)}$ tC18과 $Oasis^{(R)}$ HLB 고체상 추출 카트리지를 사용하여 비교한 결과 $Sep-Pak^{(R)}$ tC18 카트리지는 57.2%의 표지 반응물이 빠져 나갔고, $Oasis^{(R)}$ HLB 카트리지는 40.6%의 표지 반응물이 빠져나가는 것을 확인할 수 있었다. Method I 표지방법의 방사화학적 수율은 $23.8{\pm}1.9%$(decay-corrected, n=4) 이었고, method II 표지방법의 방사화학적 수율은 $31.9{\pm}6.7%$(decay-corrected, n=10) 이었다. 본 연구를 통해 전처리 정제과정을 거쳐 HPLC로 분리정제하는 방법과 전처리 정제과정을 거치지 않고 표지반응물을 바로 HPLC 정제하는 표지방법을 상용화된 자동합성장치를 사용하여 성공적으로 개발하였다. 하지만 전처리 정제과정을 포함한 표지방법은 표지반응물의 손실이 많아 방사화학적 수율이 낮아지는 단점을 발견하였다. 본 연구에서 개발된 전처리 정제과정이 생략된 $^{18}F-THK5351$의 표지방법은 향후 통상적으로 생산 시 보다 유용한 표지방법으로 사용될 것으로 기대된다.